Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes

US Patent 9138426 · Granted Sep 22, 2015

Estimated economic value: $66,869,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NK3 modulators and uses thereof2025
Bottle2024
AMPK activators2023
Chromane monobactam compounds for the treatment of bacterial infections2022
Biaryl monobactam compounds and methods of use thereof for the treatment of bact2022
Antidiabetic tricyclic compounds2019
Tricyclic compounds as inhibitors of mutant IDH enzymes2019
Tricyclic compounds as inhibitors of mutant IDH enzymes2019
Antidiabetic tricyclic compounds2018
Antidiabetic tricyclic compounds2018
Azabenzimidazole tetrahydrofuran derivatives2018
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the2017